Citation Impact
Citing Papers
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
2006 StandoutScience
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
2006 Standout
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
The role of liquid–liquid phase separation in aggregation of the TDP-43 low-complexity domain
2019 Standout
A Critical Assessment of Interleukin‐1 (IL‐1) Genotyping When Used in a Genetic Susceptibility Test for Severe Chronic Periodontitis
2002
Nasopharyngeal carcinoma
2005 Standout
Hepatitis B Virus Infection: Epidemiology and Vaccination
2006 Standout
Desensitization to allopurinol in patients with gout and cutaneous reactions
1992
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Vitamin D Deficiency
2007 Standout
Design and development of polymers for gene delivery
2005 Standout
Hepatitis B virus infection
2009 Standout
Hepatitis B vaccines
2003
Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient
2001
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Elevated antibody titers to Epstein‐Barr virus prior to the diagnosis of Epstein‐Barr‐virus‐associated gastric adenocarcinoma
1995
Global cancer statistics
2011 Standout
Nasopharyngeal carcinoma
2015 Standout
Gout
2016 Standout
S-Nitrosylation of Heterogeneous Nuclear Ribonucleoprotein A/B Regulates Osteopontin Transcription in Endotoxin-stimulated Murine Macrophages
2004
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
2006 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Periodontal diseases
2005 Standout
A Novel, Recombinant Triple Antigen Hepatitis B Vaccine (Hepacare<sup>®</sup>)
2001
Efficacy and safety of desensitization to allopurinol following cutaneous reactions
2001
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
2013
Protein S-nitrosylation: purview and parameters
2005 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
Gene Therapy for Infectious Diseases
1998
Improved Accuracy of Detection of Nasopharyngeal Carcinoma by Combined Application of Circulating Epstein–Barr Virus DNA and Anti-Epstein–Barr Viral Capsid Antigen IgA Antibody
2004
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Mammalian telomere dynamics: healing, fragmentation shortening and stabilization
1994 StandoutNobel
Long‐term T‐cell‐mediated immunity to epstein‐barr virus in man. IV. Development of T‐cell memory in convalescent infectious mononucleosis patients
1980
Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance
2003
HLA and nasopharyngeal carcinoma in chinese —A further study
1983
IgA antibody, antibody‐dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma
1981
Nuclear Proteins That Bind the Pre-mRNA 3' Splice Site Sequence r(UUAG/G) and the Human Telomeric DNA Sequence d(TTAGGG)n
1993 Nobel
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs
1995
A case control study on immunity to two epstein‐barr virus‐associated antigens, and to herpes simplex virus and adenovirus in a population‐based group of patients with hodgkin's disease in denmark, 1971–73
1977
Gout
2021 Standout
Viruses in Human Cancers
1991 StandoutScienceNobel
Global cancer statistics, 2012
2015 Standout
Epidemiology of gastric cancer
2006 Standout
Works of S.H. Chan being referenced
Influence of gender and age at onset on the HLA associations in Chinese with Insulin-dependent diabetes mellitus
1995
HLA and Allopurinol Drug Eruption
1989
Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre‐S components of the HBV coat protein with non pre‐S containing vaccines
1995
Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity
1992
Enzyme‐Linked immunosorbent assay (ELISA) for IgA and IgG antibodies to epstein‐barr‐virus ribonucleotide reductase in patients with nasopharyngeal carcinoma
1994
A comparison of the prognostic value of antibody‐dependent lymphocyte cytotoxicity and other ebv antibody assays in Chinese patients with nasopharyngeal carcinoma
1979
Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II
1992
Lymphocyte responses to ebv‐associated antigens in infectious mononucleosis, and hodgkin's and non‐hodgkin's lymphoma patients, with the leukocyte adherence inhibition assay
1977
A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation.
1996